Myomo, Inc. (MYO) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
MYO Revenue Growth
Revenue Breakdown (FY 2024)
MYO's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
MYO Revenue Analysis (2014–2025)
As of May 8, 2026, Myomo, Inc. (MYO) generated trailing twelve-month (TTM) revenue of $41.2 million, reflecting modest growth of +2.9% year-over-year. The most recent quarter (Q1 2026) recorded $10.1 million in revenue, down 10.9% sequentially.
Looking at the longer-term picture, MYO's 5-year compound annual growth rate (CAGR) stands at +40.1%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $40.9 million in 2025, representing a new all-time high.
Revenue diversification analysis shows MYO's business is primarily driven by Product (100%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including BFLY (+20.2% YoY), ATEC (-7.4% YoY), and OSUR (-47.3% YoY), MYO has underperformed the peer group in terms of revenue growth. Compare MYO vs BFLY →
MYO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| MYOCurrent | $41M | +2.9% | +40.1% | -35.2% | |
 BFLY | $98M | +20.2% | +16.1% | -88.5% | |
 ATEC | $764M | -7.4% | +39.5% | -10.7% | |
 OSUR | $115M | -47.3% | -7.7% | -59.2% | |
 GMED | $2.9B | +23.5% | +30.1% | 16.3% | |
 NVCR | $655M | +8.5% | +5.8% | -23.5% |
MYO Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $40.9M | +25.7% | $26.9M | 65.7% | $-14,401,847 | -35.2% |
| 2024 | $32.6M | +69.2% | $23.2M | 71.2% | $-6,206,698 | -19.1% |
| 2023 | $19.2M | +23.7% | $13.2M | 68.5% | $-8,231,549 | -42.8% |
| 2022 | $15.6M | +12.3% | $10.3M | 65.9% | $-10,672,204 | -68.6% |
| 2021 | $13.9M | +82.7% | $10.3M | 74.4% | $-10,268,065 | -74.1% |
| 2020 | $7.6M | +97.6% | $5.0M | 65.7% | $-10,502,686 | -138.5% |
| 2019 | $3.8M | +57.0% | $2.9M | 76.1% | $-10,795,003 | -281.3% |
| 2018 | $2.4M | +56.8% | $1.7M | 70.2% | $-10,528,417 | -430.8% |
| 2017 | $1.6M | +41.3% | $1.1M | 67.6% | $-6,548,114 | -420.1% |
| 2016 | $1.1M | +60.0% | $821K | 74.4% | $-3,275,002 | -296.8% |
See MYO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs MYO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare MYO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonMYO — Frequently Asked Questions
Quick answers to the most common questions about buying MYO stock.
Is MYO's revenue growth accelerating or slowing?
MYO revenue growth slowed to +2.9%, below the 5-year CAGR of +40.1%. TTM revenue is $41M. The deceleration marks a shift from historical growth rates.
What is MYO's long-term revenue growth rate?
Myomo, Inc.'s 5-year revenue CAGR of +40.1% reflects the variable expansion pattern. Current YoY growth of +2.9% is near this long-term average.
How is MYO's revenue distributed by segment?
MYO reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.